Oligonucleotide Synthesis (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) Market - Global Forecast to 2019

DUBLIN, Sept. 29, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Oligonucleotide Synthesis Market by Product & Services, End-User , Application - Global Forecast to 2019" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

The global oligonucleotide synthesis market is expected to reach $1,712.1 million by 2019 from $1,070.7 million in 2014, growing at a CAGR of 9.8% from 2014 to 2019. The global oligonucleotide synthesis market is categorized on the basis of products and services, applications, end users, and geography. The synthesized oligonucleotides segment is expected to register the highest growth rate in the oligonucleotide synthesis market during the forecast period, owing to an increasing number of applications for synthesized oligonucleotides in research, diagnostics and therapeutics; and a growing demand for custom oligos.

Major factors contributing to growth of the oligonucleotide synthesis market include growing R&D expenditure in pharmaceutical and biotech companies; emerging applications of oligos in molecular diagnostics and synthetic biology; and evolving significance of RNA-interference oligos in therapeutics and diagnostics. Furthermore, government support and venture capital funding are other major factors that will boost the growth of this market. For instance, the U.S. National Institutes of Health (NIH) spend $1.5 billion per year to support their oligonucleotide-based applications. Further, in January 2013, Solstice Biologics, a South California start-up, raised $18 million in a series-A financing backed by venture capital funding for targeting and delivery of nucleic acid therapeutics. The relatively-untapped markets of the Asia-Pacific (APAC) region and the increasing R&D activities and funding there have opened up an array of opportunities for the oligonucleotide synthesis market. However, factors such as regulatory barriers, especially for therapeutic oligos, and downward pricing pressure may restrain the growth of this market.

Apart from the comprehensive geographic and product analysis, and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by players in the industry over the last three years. In addition, the company profiles comprise the key players in the oligonucleotide synthesis market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output, in order to remain successful.

Reasons to Buy the Report:

The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Global Oligonucleotide Synthesis Market By Products & Services

8 Global Oligonucleotide Synthesis Market, By Application

9 Global Oligonucleotide Synthesis Market, By End User

10 Geographic Analysis

11 Competitive Landscape

12 Company Profile

13 Appendix

Companies Mentioned:

• Bioautomation Corporation
• Biosearch Technologies, Inc.
• Eurofins Genomics (A Subsidiary of Eurofins Scientific Group)
• Eurogentec (A Subsidiary of Kaneka Corporation)
• GE Healthcare (A Subsidiary of General Electric Company)
• Genedesign, Inc.
• Integrated Dna Technologies
• Sigma-Aldrich Corporation
• Thermo Fisher Scientific, Inc.
• Trilink Biotechnologies, Inc.

For more information visit http://www.researchandmarkets.com/research/qthdx9/oligonucleotide

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net